MASINI, Laura
MASINI, Laura
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
2021-01-01 Peraldo-Neia, C.; Ostano, P.; Mello-Grand, M.; Guana, F.; Gregnanin, I.; Boschi, D.; Oliaro-Bosso, S.; Pippione, A. C.; Carenzo, A.; De Cecco, L.; Cavalieri, S.; Micali, A.; Perrone, F.; Averono, G.; Bagnasacco, P.; Dosdegani, R.; Masini, L.; Krengli, M.; Aluffi-Valletti, P.; Valente, G.; Chiorino, G.
Application of a smart [18F] FDG-PET adaptive threshold segmentation algorithm for the biological target volume delineation in head and neck cancer
2022-01-01 Deantonio, Letizia; Vigna, Luca; Paolini, Marina; Matheoud, Roberta; Sacchetti, Gian Mauro; Masini, Laura; Loi, Gianfranco; Brambilla, Marco; Krengli, Marco
Application of failure mode and effect analysis (FMEA) to intracranial sterotactic radiosurgery by linear accelerator
2014-01-01 Masini, L; Donis, L; Loi, G; Mones, E; Molina, E; Bolchini, C; Krengli, Marco
Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
2021-01-01 Pisani, C.; Vigna, L.; Mastroleo, F.; Loi, G.; Amisano, V.; Masini, L.; Deantonio, L.; Aluffi Valletti, P.; Sacchetti, G.; Krengli, M.
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.
2019-01-01 Pedretti, Sara; Masini, Laura; Turco, Enrico; Triggiani, Luca; Krengli, Marco; Meduri, Bruno; Pirtoli, Luigi; Borghetti, Paolo; Pegurri, Ludovica; Riva, Nada; Gatta, Roberto; Fusco, Vincenzo; Scoccianti, Silvia; Bruni, Alessio; Ricardi, Umberto; Santoni, Riccardo; Magrini, Stefano M; Buglione, Michela
Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis
2019-01-01 Terrazzino, Salvatore; Cargnin, Sarah; Deantonio, Letizia; Pisani, Carla; Masini, Laura; Canonico, Pier Luigi; Genazzani, Armando A.; Krengli, Marco
Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma
2021-01-01 Azzimonti, B.; Raimondo, L.; Squarzanti, D. F.; Rosso, T.; Zanetta, P.; Aluffi Valletti, P.; Chiusa, L.; Masini, L.; Pecorari, G.; Airoldi, M.; Krengli, M.; Giovarelli, M.; Valente, G.
Pulmonary changes after radiotherapy for conservative treatment of breast cancer: a prospective study
2008-01-01 Krengli, Marco; Sacco, M.; Loi, G.; Masini, L.; Ferrante, Daniela; Gambaro, G.; Ronco, Marco; Magnani, Corrado; Carriero, Alessandro
Radiotherapy for vestibular schwannoma: Review of recent literature results
2016-01-01 Apicella, G; Paolini, M; Deantonio, Letizia; Masini, L; Krengli, Marco
Targeted next-generation sequencing for the identification of genetic predictors of radiation-induced late skin toxicity in breast cancer patients: A preliminary study
2021-01-01 Cargnin, S.; Barizzone, N.; Basagni, C.; Pisani, C.; Ferrara, E.; Masini, L.; D'Alfonso, S.; Krengli, M.; Terrazzino, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AKR1C3 is a biomarker and druggable target for oropharyngeal tumors | 1-gen-2021 | Peraldo-Neia, C.; Ostano, P.; Mello-Grand, M.; Guana, F.; Gregnanin, I.; Boschi, D.; Oliaro-Bosso, S.; Pippione, A. C.; Carenzo, A.; De Cecco, L.; Cavalieri, S.; Micali, A.; Perrone, F.; Averono, G.; Bagnasacco, P.; Dosdegani, R.; Masini, L.; Krengli, M.; Aluffi-Valletti, P.; Valente, G.; Chiorino, G. | |
| Application of a smart [18F] FDG-PET adaptive threshold segmentation algorithm for the biological target volume delineation in head and neck cancer | 1-gen-2022 | Deantonio, Letizia; Vigna, Luca; Paolini, Marina; Matheoud, Roberta; Sacchetti, Gian Mauro; Masini, Laura; Loi, Gianfranco; Brambilla, Marco; Krengli, Marco | |
| Application of failure mode and effect analysis (FMEA) to intracranial sterotactic radiosurgery by linear accelerator | 1-gen-2014 | Masini, L; Donis, L; Loi, G; Mones, E; Molina, E; Bolchini, C; Krengli, Marco | |
| Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma | 1-gen-2021 | Pisani, C.; Vigna, L.; Mastroleo, F.; Loi, G.; Amisano, V.; Masini, L.; Deantonio, L.; Aluffi Valletti, P.; Sacchetti, G.; Krengli, M. | |
| Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial. | 1-gen-2019 | Pedretti, Sara; Masini, Laura; Turco, Enrico; Triggiani, Luca; Krengli, Marco; Meduri, Bruno; Pirtoli, Luigi; Borghetti, Paolo; Pegurri, Ludovica; Riva, Nada; Gatta, Roberto; Fusco, Vincenzo; Scoccianti, Silvia; Bruni, Alessio; Ricardi, Umberto; Santoni, Riccardo; Magrini, Stefano M; Buglione, Michela | |
| Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis | 1-gen-2019 | Terrazzino, Salvatore; Cargnin, Sarah; Deantonio, Letizia; Pisani, Carla; Masini, Laura; Canonico, Pier Luigi; Genazzani, Armando A.; Krengli, Marco | |
| Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma | 1-gen-2021 | Azzimonti, B.; Raimondo, L.; Squarzanti, D. F.; Rosso, T.; Zanetta, P.; Aluffi Valletti, P.; Chiusa, L.; Masini, L.; Pecorari, G.; Airoldi, M.; Krengli, M.; Giovarelli, M.; Valente, G. | |
| Pulmonary changes after radiotherapy for conservative treatment of breast cancer: a prospective study | 1-gen-2008 | Krengli, Marco; Sacco, M.; Loi, G.; Masini, L.; Ferrante, Daniela; Gambaro, G.; Ronco, Marco; Magnani, Corrado; Carriero, Alessandro | |
| Radiotherapy for vestibular schwannoma: Review of recent literature results | 1-gen-2016 | Apicella, G; Paolini, M; Deantonio, Letizia; Masini, L; Krengli, Marco | |
| Targeted next-generation sequencing for the identification of genetic predictors of radiation-induced late skin toxicity in breast cancer patients: A preliminary study | 1-gen-2021 | Cargnin, S.; Barizzone, N.; Basagni, C.; Pisani, C.; Ferrara, E.; Masini, L.; D'Alfonso, S.; Krengli, M.; Terrazzino, S. |